Lance Baldo (@LanceBaldoMD) profile picture

Chief Medical Officer, Freenome

Joined December 2019
Proud to co-author this new publication with my fellow colleagues and Adapters.
More extensive deployment of existing methods for measuring T-cell immunity to SARS-CoV-2 could provide a more complete profile of the immune status for at risk populations and offer insights for informing public health interventions. Read @SciImmunology: adaptivebio.tech/zye
5
A Viewpoint by @SantoshVardhana @LanceBaldoMD @moricemdphd and @EJohnWherry explains how #Tcell testing can help research on population-level #SARSCoV2 #AdaptiveImmunity and inform public health policies. fcld.ly/k7wvnub
2
27
3
63
It was an honor to sit down with @MedicalWrldNews for a discussion of findings from our recent @Nature article on the T-cell response generated by the J&J (@JNJNews) COVID-19 vaccine to #COVID19 variants.
As new variants spread, many are wondering how effective current #COVID19 vaccines will continue to be. CMO @LanceBaldoMD shares insights from a @Nature paper on how measuring T-cells can answer these questions and more. Watch the interview at medicalworldnews.com/view/in….
1
5
Data science never mattered so much as it does now. Grateful for the opportunity to partner with @Microsoft and hear the diversity of perspectives on the future of big data in medicine.
Protecting patient privacy 🔒 Identifying life-changing drugs 🔎 Helping cancer specialists 🥼 Data sharing is revolutionizing healthcare. Learn more: msft.it/6004nuajj

7
Congratulations to our partners at @microsoft on their brilliant new Resilience series highlighting the community response to #COVID19 and the role science and technology have played in the pandemic. microsoft.com/societal-resil… #SocietalResilience #Got2Adapt
3
Great NYT coverage of the work we are doing to develop a T cell diagnostic.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
6